Leads clinical development strategy for hepatology assets within GSK's Respiratory, Immunology & Inflammation Research Unit, from target identification through proof-of-concept studies. Accountable for clinical matrix team leadership, protocol design, medical monitoring and regulatory interactions across all development phases. Hybrid role with at least two on-site days weekly.
Leads clinical development strategy for hepatology assets within the Respiratory, Immunology & Inflammation Research Unit, overseeing study design, medical monitoring, and regulatory interactions. Accountable for the Clinical Matrix Team, target validation, translational plans, and Go/No Go decision criteria across early-phase programs. Hybrid role requiring on-site presence at least two days per week.
Senior physician leader providing medical oversight, safety monitoring and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional groups on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence at least two days a week.
Owns the backlog and roadmap for GSK's voice and collaboration product, prioritising work by value, risk and reliability and linking every item to strategy and OKRs. Works daily with engineering on refinement, planning and acceptance, steering delivery with flow metrics and using AI tooling for discovery and requirement drafting.
Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and interacts with regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.
Provides medical and scientific leadership in safety evaluation and risk management for oncology assets in clinical development, interpreting safety data, escalating signals and delivering evidence-based benefit-risk recommendations. Leads Safety Review Teams and cross-functional matrix groups, representing Safety to governance committees and regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.
Provides medical and scientific leadership in pharmacovigilance and risk management for oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and Safety Review Teams, and presents to senior governance committees and regulators. Hybrid role based in the UK, Belgium, Poland or Italy.
Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. The role is hybrid across the UK, Belgium, Poland or Italy, with on-site attendance for key meetings.
Senior individual contributor shaping GSK's Enterprise AI portfolio for technology and R&D portfolio management, from intake and prioritization through funding, resource allocation and benefits tracking. Combines hands-on prototyping of LLM and agentic systems with executive-level business cases, opportunity sizing and operating-model redesign, without managing engineers.
Leads clinical development medical activities for cardiovascular and vascular programs across early and later phase studies, shaping clinical development plans, study designs and translational strategies. Provides medical monitoring and safety oversight, leads the clinical matrix team, and engages with regulators, KOLs and cross-functional partners in a hybrid working model.
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and serves as asset spokesperson to senior governance boards.
Leads clinical development medical activities for cardiovascular and vascular programs across early and later phase studies, shaping clinical development plans, study designs and translational strategies. Serves as clinical lead for a matrix team, providing medical monitoring, regulatory input and safety oversight while working with biology, regulatory, commercial and operations colleagues.
